Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
 Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
27.13799
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
0
30,684
20,034.7188
19,159
29.5
white
22.898438
29
0.910889
0.87793
1
0
0
no
0.7
0.7
no dnr
11
114
9.699219
103
20
36.79688
361.875
null
0.5
0.799927
123
7.469727
144
17
800
0
0
null
0
923
0
33.53
female
0
4
CHF
COPD/CHF/Cirrhosis
2
14
under $11k
0
5,940
3,547.0684
3,059
5
black
10.099609
6
0.966919
0.94397
1
1
0
no
null
null
no dnr
4
146
20.898438
60
28
38.5
350
null
null
1.5
147
7.459961
102
31
2,195
0
null
no(M2 and SIP pres)
0.494751
922
0
70.04199
male
1
14
COPD
COPD/CHF/Cirrhosis
1
8
null
0
58,371
38,666.5
33,197
36
white
28.5
47
0.688965
0.521973
2
0
0
no
0.65
0.5
dnr after sadm
14
123
20
135
33
38.79688
212.5
2.299805
1
0.699951
143
7.529297
98
14
1,615
null
0
<2 mo. follow-up
0
14
1
48.83798
male
0
101
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
>$50k
0
562,579
343,860.25
315,256
44.5
white
28
49
0.724976
0.639893
67
0
0
no
0.9
0.9
no dnr
101
58
18
120
10
36.69531
151
1.599854
0.399963
2.5
141
7.359375
70
37
1,935
null
1
adl>=4 (>=5 if sur)
1
921
0
23.99199
male
0
35
Coma
Coma
2
13
under $11k
44
204,389
143,170.875
135,740
27
white
30
53
0.626953
0.565918
8
0
0
no
null
null
no dnr
35
128
22.097656
150
40
36.5
288
null
1.299805
2.599609
135
7.30957
214
45
2,110
null
1
no(M2 and SIP pres)
1
921
0
49.383
female
0
5
Lung Cancer
Cancer
1
null
null
0
7,343
3,871.666
2,215
11
white
19.097656
14
0.702881
0.416992
1
0
0
metastatic
1
0.9
no dnr
5
108
12.099609
135
35
36.09375
256.625
2.799805
0.299988
0.5
143
7.5
155
12
3,155
null
null
null
2.093262
231
1
61.67599
male
1
5
Colon Cancer
Cancer
1
8
$11-$25k
0
2,958
1,935.3555
1,559
15
black
34.398438
44
0.447998
0.136993
1
0
0
metastatic
0
0
no dnr
5
105
9.298828
135
6
35.79688
395.1875
null
5.199219
5.099609
137
7.469727
383
101
1,040
null
7
<2 mo. follow-up
7
5
1
74.97095
male
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
96,936
58,131.75
65,039
22.25
white
26.296875
41
0.674927
0.579956
6
0
0
no
0.65
0.6
no dnr
26
70
14.199219
120
29
38.79688
106
null
null
1.099854
133
7.5
211
44
1,175
null
0
null
0
920
0
76.53699
female
1
3
MOSF w/Malig
ARF/MOSF
1
16
$25-$50k
61
17,981
10,559.3828
8,841
50
black
73.296875
76
0
0
2
1
0
yes
null
null
no dnr
3
58
18.199219
70
14
39.09375
96.65625
null
null
1.199951
141
7.459961
104
36
1,550
null
0
<2 mo. follow-up
0
3
1
63.96997
male
0
16
CHF
COPD/CHF/Cirrhosis
1
8
null
41
33,433
19,486.6562
18,911
22.666656
black
51.195313
86
0.036995
0.003
1
0
0
no
0.3
0.15
dnr after sadm
3
66
16.597656
64
28
32.19531
null
2.299805
2.099609
1.399902
151
null
189
18
125
1
6
no(M2 and SIP pres)
6
113
1
80.58295
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
null
0
48,776
28,987.375
36,857
50
white
39.296875
62
0.258972
0.153992
12
1
0
no
0.1
0
dnr after sadm
2
117
7.399414
100
24
36.39844
240
null
null
1.299805
141
7.449219
87
22
100
null
null
<2 mo. follow-up
2.908203
5
1
75.56195
male
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
null
0
75,121
48,257.625
49,827
12.75
white
23.398438
30
0.704956
0.615967
18
0
0
no
null
null
no dnr
34
80
5.699219
125
22
35.69531
null
null
1
1.299805
142
null
78
21
1,000
null
6
no(M2 and SIP pres)
6
917
0
83.46594
female
0
17
Coma
Coma
1
8
under $11k
61
41,887
null
null
24
black
21.097656
48
0.238983
0.173981
4
0
0
no
0.1
0.1
dnr after sadm
2
128
7.699219
110
12
35.39844
264
null
24
10.898438
131
7.509766
100
68
2,980
null
0
<2 mo. follow-up
0
23
1
78.12195
male
0
13
COPD
COPD/CHF/Cirrhosis
4
6
under $11k
0
23,784
14,434.2188
16,695
20
white
24.597656
40
0.654907
0.477966
1
1
0
yes
0.75
0.6
no dnr
13
57
3.299805
115
12
36
117.76562
2.299805
0.5
7.899414
126
7.369141
374
73
900
3
5
SIP>=30
5
341
1
59.66599
male
0
5
Lung Cancer
Cancer
1
12
$11-$25k
0
7,854
4,179
3,162
14
white
17.5
16
0.710938
0.429993
1
0
0
metastatic
0.8
0.5
no dnr
5
102
12.898438
114
24
36.39844
365.1875
3.799805
0.399963
1.299805
144
7.429688
199
15
null
1
2
null
2
233
1
37.86697
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
37
35,427
24,140.5781
20,114
40.5
black
44.695313
87
0.315979
0.201996
1
1
0
no
0.1
0.05
dnr after sadm
8
80
9.398438
75
8
37.79688
368
null
null
0.5
142
7.419922
117
4
4,520
null
null
<2 mo. follow-up
2.927734
8
1
73.59296
male
0
30
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
41
100,898
59,514.1562
64,135
33
white
28.296875
42
0.496948
0.378967
2
0
0
no
0.5
0.3
no dnr
30
115
16.796875
115
12
36.19531
128.5625
null
0.699951
4.899414
133
7.40918
108
72
4,185
null
0
no(M2 and SIP pres)
0
916
0
68.33698
male
0
94
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$25-$50k
0
324,557
193,135
211,562
34.75
white
27.5
36
0.698975
0.60791
4
0
0
no
0.75
0.6
no dnr
94
73
5.099609
128
20
36.39844
null
2.5
0.399963
0.699951
132
null
520
6
200
null
0
adl>=4 (>=5 if sur)
0
916
0
37.55499
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
null
0
58,201
41,127.0938
38,203
27
white
37.898438
60
0.655884
0.556885
2
0
0
no
0.8
0.7
no dnr
18
108
5.399414
135
35
38.39844
142.5
1.5
8.5
1.099854
145
7.399414
52
20
2,180
null
0
no(M2 and SIP pres)
0
916
0
68.58295
male
1
6
Lung Cancer
Cancer
1
21
null
9
9,984
5,991.3438
6,257
7
white
19.199219
43
0.615967
0.300964
1
0
0
metastatic
0.4
0.2
dnr after sadm
5
115
14.5
145
36
36.5
253.3125
2.899902
0.199982
2
134
7.469727
122
20
5,510
null
null
<2 mo. follow-up
2.272461
6
1
54.021
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
0
89,819
52,582.5938
52,400
28.666656
white
24.597656
19
0.820923
0.760986
2
0
0
no
0.9
0.85
no dnr
23
92
5.099609
70
20
37
null
1
3.799805
0.799927
136
null
69
10
4,900
null
0
SIP>=30
0
914
0
18.84999
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
$25-$50k
0
112,985
72,790.5
68,755
18
white
25.398438
48
0.889893
0.850952
4
0
0
no
0.75
0.75
no dnr
27
93
22.398438
100
10
37.59375
182.5
2.399902
6.199219
5.899414
137
7.319336
99
97
3,040
0
0
no(M2 and SIP pres)
0
914
0
55.96698
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
null
0
81,191
48,240.375
52,100
25.666656
white
18.398438
30
0.869995
0.823975
5
0
0
no
0.9
0.8
no dnr
22
163
14.398438
55
14
38.29688
245
3.799805
null
1.399902
148
7.519531
192
16
3,005
null
0
no(M2 and SIP pres)
0
913
0
67.81696
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
under $11k
0
36,085
22,808.9688
21,588
18.666656
white
16
35
0.873901
0.828979
3
0
0
no
0.98
0.9
no dnr
16
88
6.599609
60
42
38.39844
255
2.799805
0.399963
0.799927
143
7.439453
96
16
5,430
null
null
no(M2 and SIP pres)
2.101074
913
0
43.87997
female
0
23
COPD
COPD/CHF/Cirrhosis
2
9
$25-$50k
0
35,225
24,241.7344
26,822
15
white
36.796875
51
0.759888
0.618896
1
0
0
no
0.85
0.75
no dnr
23
75
6
60
8
38.09375
360
2.699707
null
0.599976
137
7.479492
90
6
3,140
6
6
no(M2 and SIP pres)
6
912
0
73.35199
male
0
6
Colon Cancer
Cancer
1
18
under $11k
0
8,575
4,780.0039
3,073
11
white
22.898438
6
0.698975
0.411987
1
0
0
metastatic
0.7
0.5
no dnr
6
78
6.199219
62
20
36.5
null
3.599609
0.699951
1.399902
135
null
78
44
1,750
1
0
no(M2 and SIP pres)
0
259
1
66.95099
male
0
6
Colon Cancer
Cancer
1
12
$25-$50k
0
9,823
5,222.8516
2,767
12
white
3.899902
16
0.930908
0.837891
1
0
0
metastatic
0.8
0.5
no dnr
6
144
12.298828
70
37
35.59375
null
null
null
2.099609
137
null
190
126
1,700
0
0
no(M2 and SIP pres)
0
652
1
27.28499
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
null
0
54,747
33,137.2188
36,116
28
white
21.796875
24
0.917969
0.887939
1
0
0
no
0.7
0.7
no dnr
17
65
10.699219
95
25
36.29688
120
1.899902
null
3
127
7.379883
132
37
170
null
0
no(M2 and SIP pres)
0
911
0
65.23199
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
90,020
53,483.9688
48,524
22.5
white
24.597656
37
0.764893
0.689941
4
0
0
no
0.75
0.65
no dnr
38
57
7.199219
145
24
36.39844
null
null
2.799805
1.399902
130
null
92
46
1,700
null
0
no(M2 and SIP pres)
0
909
0
62.27197
male
0
12
Lung Cancer
Cancer
1
10
$11-$25k
0
12,126
8,072.0898
8,354
6
white
17
11
0.713989
0.43396
1
0
0
metastatic
0.6
0.2
dnr after sadm
5
58
7.799805
65
44
35
188.5625
null
0.399963
1.799805
136
7.429688
191
25
330
null
6
<2 mo. follow-up
6
44
1
64.69495
male
1
18
CHF
COPD/CHF/Cirrhosis
4
7
$11-$25k
37
75,950
43,130.25
46,996
35.666657
white
27.398438
40
0.60791
0.419983
2
0
0
no
0.9
0.8
dnr after sadm
17
30
13.599609
0
0
37.19531
152.5
null
null
1.5
131
7.419922
169
25
72
null
4
<2 mo. follow-up
4
18
1
54.89697
female
0
8
Lung Cancer
Cancer
1
16
>$50k
0
6,629
4,383.3828
5,313
4.5
white
19.796875
3
0.675903
0.378967
1
0
0
metastatic
0
0
dnr after sadm
2
139
16.898438
70
22
37.69531
280.9375
null
0.399963
1.799805
144
7.349609
99
66
2,300
null
5
adl>=4 (>=5 if sur)
5
127
1
47.96198
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
null
0
37,890
null
null
28
black
23.5
47
0.844971
0.791992
3
1
0
no
1
1
no dnr
11
55
33.195313
50
12
39.09375
120
null
2.299805
4.799805
131
7.349609
69
75
144
2
4
SIP>=30
4
814
1
57.84
female
0
140
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
0
null
581,140
494,838
37.75
white
24
45
0.701904
0.612915
66
0
0
yes
null
null
no dnr
140
148
20.199219
115
28
36.29688
126.65625
2.5
null
3.799805
147
7.439453
69
64
46
null
0
adl>=4 (>=5 if sur)
0
906
0
63.73199
female
0
47
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
143,396
83,986.8125
83,146
38.75
white
34.296875
57
0.540894
0.426941
1
0
0
yes
0.6
0.5
no dnr
47
68
12
100
36
35
256.625
null
null
0.899902
137
7.469727
173
30
2,435
null
0
no(M2 and SIP pres)
0
903
0
72.32898
female
1
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
122,706
70,672.0625
72,596
38.666657
white
26.5
48
0.680908
0.586914
7
0
0
no
0.6
0.6
dnr after sadm
8
115
0.699951
30
11
36.39844
188.5625
3.099609
0.899902
1
136
7.469727
96
18
4,470
null
0
<2 mo. follow-up
0
17
1
62.89899
male
0
156
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
0
null
483,192.5
424,471
48.5
white
31.199219
44
0.587891
0.478943
28
0
0
no
0.4
0.064
no dnr
156
63
15.199219
65
24
37.79688
257.125
2.299805
0.699951
1.699951
143
7.369141
93
47
3,015
null
1
adl>=4 (>=5 if sur)
1
903
0
44.16699
female
1
53
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
141,044
88,699.5
46,605
24.25
hispanic
29.296875
74
0.802979
0.736938
1
0
0
no
0.7
0.65
no dnr
53
58
27.699219
130
28
36.5
185.6875
null
0.599976
1.399902
138
7.479492
337
68
3,440
null
0
<2 mo. follow-up
0
53
1
85.89996
male
1
57
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
253,935
147,299.375
81,815
41.25
white
20.796875
37
0.711914
0.625
2
0
0
yes
null
null
dnr after sadm
55
100
9.398438
85
22
36.59375
null
null
0.599976
0.899902
137
null
129
16
1,900
null
0
<2 mo. follow-up
0
57
1
58.13797
male
0
32
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$25-$50k
0
117,341
67,746.375
62,858
28.5
white
29.5
54
0.677979
0.582886
10
0
0
no
null
null
no dnr
32
72
18.398438
100
14
37.79688
155
3
null
3.099609
131
7.449219
102
53
1,990
null
2
adl>=4 (>=5 if sur)
2
681
1
66.97296
male
1
10
MOSF w/Malig
ARF/MOSF
1
19
$11-$25k
0
27,791
17,151.7656
17,346
13.5
white
27
31
0.542969
0.428955
9
0
0
yes
0.7
0.4
dnr after sadm
1
72
8.798828
105
40
38
230
3.799805
0.5
1.199951
139
7.459961
94
13
2,830
null
0
<2 mo. follow-up
0
10
1
81.26996
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
null
0
69,968
39,407.5625
40,857
45.5
white
49.695313
80
0.056
0.017998
5
0
0
no
0.25
0.25
no dnr
11
135
17.296875
105
12
36.69531
514.25
2.699707
0.5
2.299805
140
7.259766
353
38
870
null
0
<2 mo. follow-up
0
11
1
61.771
male
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
51,834
30,533.4219
30,175
31
white
33.5
44
0.574951
0.464966
1
0
0
yes
0.4
0.2
dnr after sadm
4
78
6.899414
115
24
38.5
186.65625
2.799805
0.599976
1.199951
130
7.429688
95
32
3,335
null
0
<2 mo. follow-up
0
16
1
44.73398
female
0
6
Lung Cancer
Cancer
1
18
>$50k
0
8,851
4,862.5469
2,920
11
white
6.5
5
0.885986
0.741943
1
0
0
metastatic
0.7
0.5
no dnr
6
72
5.399414
105
24
35.19531
null
3.299805
2.799805
1.5
123
null
108
34
2,950
0
0
no(M2 and SIP pres)
0
554
1
63.69299
female
0
5
COPD
COPD/CHF/Cirrhosis
1
null
null
0
4,883
3,504.1641
3,108
12
black
16.796875
19
0.898926
0.829956
1
0
0
no
0.75
0.5
no dnr
5
93
7.599609
70
20
36.29688
228.5625
3.799805
0.5
2.799805
135
7.40918
220
61
1,900
1
0
no(M2 and SIP pres)
0
902
0
57.61298
male
0
9
Colon Cancer
Cancer
1
12
$25-$50k
0
13,696
8,415.9453
7,827
9
white
17.699219
6
0.820923
0.612915
1
0
0
metastatic
null
null
no dnr
9
107
5.199219
70
18
36.39844
null
3.799805
0.399963
1
138
null
103
11
1,000
null
null
no(M2 and SIP pres)
2.310547
604
1
74.79797
female
0
14
Colon Cancer
Cancer
1
12
$11-$25k
0
22,498
13,941.4922
13,036
9.666664
white
14.798828
9
0.828979
0.62793
1
0
0
metastatic
null
null
no dnr
14
103
11.5
110
26
36.09375
246.65625
1.699951
5.099609
3.899902
136
7.429688
319
73
2,705
0
0
no(M2 and SIP pres)
0
901
0
24.709
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
0
135,950
75,986.9375
73,674
37.5
black
40.5
75
0.687988
0.594971
1
0
0
no
0.5
0.5
no dnr
27
72
16.597656
55
26
36.19531
177.125
2.399902
0.399963
1.199951
141
7.419922
92
19
5,445
null
0
null
0
900
0
92.31995
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
23,363
14,359.7891
13,182
22.5
white
73.390625
75
0
0
1
0
0
yes
0.5
0.25
dnr after sadm
2
117
6.199219
75
22
36.39844
null
4.199219
0.5
0.799927
140
null
84
9
2,960
null
3
<2 mo. follow-up
3
32
1
47.31299
male
0
40
Colon Cancer
Cancer
1
null
null
0
55,251
33,087.5312
30,881
10.75
white
16.699219
16
0.849976
0.668945
1
0
0
metastatic
null
null
no dnr
40
55
14.898438
130
30
35.69531
296
null
null
1.299805
136
7.339844
151
44
1,940
null
null
null
2.266602
76
1
56.41098
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
under $11k
0
106,196
54,926.6562
56,044
52
white
79.6875
94
0
0
3
0
0
no
0.75
0.75
dnr after sadm
14
72
32
115
28
38
185
2.099609
5
1.199951
148
7.439453
134
26
6,115
null
0
<2 mo. follow-up
0
15
1
51.51797
female
0
18
Lung Cancer
Cancer
1
11
$11-$25k
0
25,189
16,071.8516
17,381
6.666664
white
17
11
0.738892
0.471985
1
0
0
metastatic
1
0.9
no dnr
18
135
12.199219
115
10
38.29688
392
2.099609
14.099609
1.199951
127
7.549805
229
17
1,545
0
1
no(M2 and SIP pres)
1
160
1
76.42395
male
0
8
Colon Cancer
Cancer
1
11
under $11k
0
9,101
5,863.6836
5,795
5.5
black
24.199219
31
0.662964
0.360962
1
0
0
metastatic
0.35
0.1
dnr after sadm
2
102
6.399414
115
20
36.5
null
null
0.299988
0.799927
135
null
95
3
2,305
1
0
no(M2 and SIP pres)
0
149
1
47.72897
male
0
23
Lung Cancer
Cancer
1
16
$25-$50k
0
37,925
22,524.75
26,891
11.666664
white
30.296875
23
0.42395
0.118988
1
0
0
metastatic
null
null
no dnr
23
98
7.699219
111
20
36.5
null
2.299805
4.099609
1
140
null
141
26
200
0
3
null
3
61
1
62.08099
male
0
16
Lung Cancer
Cancer
1
14
$11-$25k
0
34,952
20,978.7188
18,468
16.333328
black
28.296875
18
0.432983
0.125
1
0
0
metastatic
0.99
0.9
no dnr
16
62
12.898438
145
44
39.59375
192.5
null
null
1.099854
137
7.469727
138
19
5,125
null
0
null
0
67
1
77.60699
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
37
48,632
28,300.7969
30,776
42
white
28
44
0.5
0.382996
2
0
0
no
0.4
0.25
dnr after sadm
4
0
24.597656
0
10
38.5
157.5
1.799805
0.599976
2.599609
148
7.339844
172
59
832
null
2
<2 mo. follow-up
2
8
1
77.17694
male
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
41
97,799
60,579.9688
18,902
28.5
black
20.796875
21
0.595947
0.487976
14
1
1
no
0.8
0.8
no dnr
46
45
13.199219
110
0
39
126.51562
null
null
2.899902
123
7.519531
83
58
230
null
null
<2 mo. follow-up
5.62793
57
1
72.83795
male
0
4
CHF
COPD/CHF/Cirrhosis
2
12
null
0
6,601
4,359.1523
3,777
16
white
28.5
48
0.701904
0.539917
1
0
0
no
null
null
no dnr
4
42
21.296875
60
10
36.69531
370
null
null
5.599609
128
7.30957
377
106
500
null
null
no(M2 and SIP pres)
2.127441
152
1
77.87
female
1
7
Coma
Coma
2
16
under $11k
61
46,219
26,834.6406
29,943
13.5
black
32.296875
54
0.011
0.004
15
0
0
yes
0.15
0.05
dnr after sadm
6
103
18.097656
95
10
36.59375
288
2.399902
1.299805
1.299805
129
7.5
104
19
2,745
null
null
<2 mo. follow-up
2.644043
7
1
53.599
female
0
10
CHF
COPD/CHF/Cirrhosis
2
8
under $11k
0
7,853
5,763.418
6,893
9
black
19.796875
8
0.892944
0.820923
1
0
0
no
0.9
0.7
no dnr
10
135
8.099609
120
4
38
283.3125
3.299805
null
1
139
7.439453
971
22
2,295
0
0
no(M2 and SIP pres)
0
895
0
71.362
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
31,418
20,014.6719
19,758
19
black
24.097656
37
0.783936
0.713989
1
0
0
no
0.9
0.9
no dnr
20
107
5.5
55
26
36.19531
186
null
0.799927
2.099609
141
7.419922
325
53
5,200
0
0
no(M2 and SIP pres)
0
892
0
68.78894
female
1
21
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
null
0
177,484
102,778.688
103,117
49
white
27.296875
70
0.664917
0.567993
12
0
0
no
0.8
0.7
dnr after sadm
18
80
14.398438
60
22
36.19531
null
3.599609
0.599976
0.899902
134
null
336
17
1,600
null
1
<2 mo. follow-up
1
21
1
73.99298
male
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
7
under $11k
0
112,800
66,367.5
65,955
31.333328
white
26.097656
56
0.498962
0.380981
24
1
0
metastatic
0.6
0.35
no dnr
20
63
24.097656
115
30
35.19531
150
2.5
17.597656
4.799805
140
7.379883
328
80
8
0
0
<2 mo. follow-up
0
20
1
60.70099
male
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
5
$25-$50k
0
100,215
56,954.2812
58,198
54.5
white
37.5
71
0.527954
0.412964
2
0
0
no
0.5
0.5
no dnr
10
70
19.597656
80
12
35.89844
167.5
null
null
5.5
134
7.379883
84
100
2,100
null
0
<2 mo. follow-up
0
10
1
44.63797
female
0
10
Lung Cancer
Cancer
2
12
under $11k
0
15,027
8,958.0078
9,747
13.5
white
39
44
0.182983
0.014999
1
0
0
metastatic
0.8
0.2
dnr after sadm
3
63
6.199219
105
30
36.89844
123.625
null
null
1.099854
132
7.459961
118
23
4,505
5
5
<2 mo. follow-up
5
39
1
60.69498
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$25-$50k
0
96,528
56,634.75
59,375
29.5
white
23
37
0.805908
0.741943
4
0
0
no
0.3
0.2
dnr after sadm
8
52
32.5
135
48
38.39844
94
null
1
0.599976
140
7.419922
117
7
3,060
null
0
adl>=4 (>=5 if sur)
0
889
0
59.44699
female
1
5
Coma
Coma
1
8
under $11k
89
24,836
15,311.375
13,256
42
black
23.796875
31
0.092987
0.054993
8
0
0
metastatic
0.05
0
dnr after sadm
3
64
67.09375
80
28
39
null
null
null
1.399902
140
null
11
26
1,000
null
null
<2 mo. follow-up
2.894531
5
1
75.95898
male
1
16
COPD
COPD/CHF/Cirrhosis
5
12
$25-$50k
0
83,494
49,170.5312
47,284
33.666657
white
30.597656
48
0.447998
0.246979
6
0
0
yes
0.5
0.5
dnr after sadm
15
70
11.898438
105
10
38.69531
154.28125
null
null
1.299805
132
7.40918
151
19
2,450
null
1
<2 mo. follow-up
1
16
1
58.37598
female
0
9
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
0
29,065
19,337.3438
18,850
19
white
25
41
0.715942
0.557983
1
0
0
no
0.7
0.5
no dnr
9
132
28.398438
135
8
38.79688
270
null
2.599609
1.399902
137
7.30957
92
48
3,180
0
0
no(M2 and SIP pres)
0
287
1
73.22095
female
0
5
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
5,317
3,414.8769
3,727
13
white
17.898438
14
0.849976
0.75293
1
0
0
no
0.75
0.75
no dnr
5
135
10.699219
65
30
38
233
null
null
0.599976
137
7.429688
99
10
5,195
0
2
no(M2 and SIP pres)
2
887
0
91.48798
female
1
6
Coma
Coma
2
null
under $11k
0
46,934
null
null
37
black
26.699219
55
0.168976
0.113998
20
0
0
yes
0
0
dnr after sadm
1
115
9.699219
75
31
38.79688
232
2.599609
0.399963
12.898438
144
7.389648
107
83
5,112
null
3
<2 mo. follow-up
3
6
1
60.28497
female
0
4
Colon Cancer
Cancer
1
9
under $11k
0
2,439
2,092.8027
2,254
8
white
11.599609
5
0.883911
0.735962
1
0
0
metastatic
0.8
0.6
no dnr
4
115
27.398438
125
10
36.29688
182.5
2.399902
0.699951
0.399963
137
7.439453
81
20
900
0
null
SIP>=30
0.494751
593
1
77.44299
male
1
31
COPD
COPD/CHF/Cirrhosis
3
8
under $11k
0
143,014
81,730
75,129
43
white
26.699219
45
0.678955
0.508911
1
0
0
no
0.5
0.5
dnr after sadm
27
83
10.599609
65
20
36.09375
null
2.899902
0.399963
1
141
null
139
11
4,900
null
0
<2 mo. follow-up
0
31
1
67.39496
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
under $11k
0
39,396
24,119.1719
22,701
48.5
white
35.296875
70
0.569946
0.457947
1
0
0
no
0.02
0.02
dnr after sadm
7
75
5.299805
60
20
36.5
null
4.5
0.5
1.099854
142
null
98
12
5,925
null
0
<2 mo. follow-up
0
8
1
55.01398
male
0
7
Lung Cancer
Cancer
2
4
$11-$25k
0
6,700
4,328.8984
5,167
6.5
white
23
26
0.598999
0.280945
1
0
0
metastatic
0.5
0.1
dnr before sadm
0
115
12.099609
80
16
38.29688
91.25
2.399902
0.5
0.899902
142
7.40918
149
10
3,910
3
3
<2 mo. follow-up
3
24
1
47.53699
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
73,925
41,813.8438
45,206
20.666656
white
24.699219
24
0.815918
0.754883
6
0
0
no
0.85
0.8
no dnr
14
72
11.599609
105
16
37.79688
180
null
null
1.899902
146
7.40918
255
58
1,675
0
0
null
0
883
0
72.00299
female
1
11
Coma
Coma
1
14
null
89
29,982
18,713.8125
16,394
23
white
20.296875
12
0.267944
0.199982
2
0
0
no
0.1
0.05
dnr after sadm
6
70
null
76
16
36.29688
null
null
null
0.5
138
null
90
4
null
null
1
<2 mo. follow-up
1
11
1
74.91895
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
3
$11-$25k
0
63,505
35,324.125
34,675
48
white
53.695313
113
0.019997
0.004
13
0
0
no
0.02
0.02
dnr after sadm
3
138
10.699219
125
10
38.69531
197.5
null
null
2.599609
133
7.519531
133
35
3,395
null
0
<2 mo. follow-up
0
5
1
30.86699
male
1
44
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
37
93,251
57,726.3438
55,655
18.5
white
42.195313
63
0.365967
0.247986
5
0
0
no
null
null
dnr after sadm
43
99
10.199219
106
20
37
null
null
null
0.599976
136
null
106
11
null
null
6
<2 mo. follow-up
6
44
1
76.646
male
0
10
CHF
COPD/CHF/Cirrhosis
2
10
under $11k
0
9,616
6,967.2773
6,610
11.5
white
21.796875
39
0.799927
0.677979
1
0
0
no
null
null
no dnr
10
68
19
105
8
39.29688
312
2.299805
1.099854
11.199219
132
7.359375
188
92
850
5
2
no(M2 and SIP pres)
2
558
1
61.89697
male
1
5
Coma
Coma
4
null
under $11k
100
25,350
14,670.7344
13,805
35
white
41.296875
75
0.001
0
5
0
0
no
0.01
0.01
dnr after sadm
4
112
21
105
28
36.39844
283.3125
1.799805
2.799805
0.699951
136
7.509766
124
48
3,280
null
null
<2 mo. follow-up
3.412109
5
1
38.83398
male
0
7
Lung Cancer
Cancer
1
16
$25-$50k
0
12,767
7,167.6797
5,134
5
white
13.699219
12
0.813965
0.600952
1
0
0
metastatic
0.7
0.4
no dnr
7
57
26
125
20
38.69531
78.75
2.599609
null
0.599976
133
7.299805
173
20
900
null
null
SIP>=30
1.891357
78
1
56.93399
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
178,049
106,424.438
118,616
27.333328
white
23.199219
31
0.726929
0.642944
36
0
0
yes
null
null
no dnr
23
117
6.899414
130
10
38.69531
140
1.199951
null
0.599976
133
7.40918
238
25
1,485
null
null
null
2.515625
880
0
63.26099
male
1
5
Coma
Coma
3
null
null
94
18,203
10,571.1016
8,207
43
black
19.597656
22
0.381958
0.307983
1
0
0
no
0
0
dnr after sadm
4
112
7.599609
120
10
36.29688
136
2.699707
0.199982
4.899414
148
7.379883
80
135
1,740
null
null
<2 mo. follow-up
2.70459
5
1
59.573
female
0
21
COPD
COPD/CHF/Cirrhosis
1
10
$25-$50k
0
28,897
18,869.1875
20,256
9
white
20.699219
15
0.863892
0.774902
3
0
0
no
null
null
no dnr
21
138
12
115
38
37.79688
220
1.899902
0.399963
5.399414
131
7.429688
114
72
780
null
null
null
2.867676
880
0
64.39398
male
0
11
MOSF w/Malig
ARF/MOSF
2
14
$25-$50k
0
51,695
30,432.25
34,388
29.5
white
23.597656
45
0.54895
0.435974
12
1
0
metastatic
null
null
no dnr
11
63
12.5
80
12
37.79688
180
2
0.799927
2.099609
137
7.379883
114
36
1,365
2
0
no(M2 and SIP pres)
0
576
1
64.02997
female
0
7
Colon Cancer
Cancer
1
20
null
0
13,248
7,570.4336
6,610
6.5
white
10.5
9
0.888916
0.745972
1
0
0
metastatic
0.9
0.8
no dnr
7
78
23.097656
120
44
38.29688
210
1.599854
3.899902
0.799927
129
7.489258
189
12
2,745
0
0
no(M2 and SIP pres)
0
192
1
39.53497
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
$25-$50k
0
47,511
29,027.0781
32,729
26.333328
black
19.296875
19
0.914917
0.883911
1
0
0
no
null
null
no dnr
15
77
20.398438
120
24
38
118
null
0.699951
1.299805
135
7.439453
206
44
null
5
6
no(M2 and SIP pres)
6
879
0
53.76297
male
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
$11-$25k
0
57,148
null
null
39.5
white
29.898438
29
0.756958
0.678955
1
0
0
no
0.7
0.65
dnr after sadm
12
40
20.199219
155
8
38.09375
54
2.099609
1.599854
2
131
7.389648
71
40
1,570
null
0
<2 mo. follow-up
0
12
1
59.73999
male
0
14
CHF
COPD/CHF/Cirrhosis
2
6
under $11k
0
39,612
23,242.3281
21,152
17.666656
white
28.597656
41
0.72998
0.576904
4
0
0
no
0.8
0.65
dnr after sadm
10
47
22
130
35
39.19531
220
2.5
0.399963
0.5
140
7.40918
89
11
2,860
1
6
no(M2 and SIP pres)
6
805
1
63.685
female
0
5
Lung Cancer
Cancer
1
null
null
0
7,560
4,113.7734
2,824
14
white
14.898438
11
0.75
0.48999
1
0
0
metastatic
1
1
no dnr
5
82
8.398438
75
20
37.19531
null
4.099609
0.399963
0.799927
141
null
122
6
null
null
null
null
2.620606
94
1
54.94299
male
0
6
Lung Cancer
Cancer
1
12
null
0
9,718
5,279.8398
2,546
14
white
21.199219
13
0.643921
0.336975
1
0
0
metastatic
0.5
0.1
no dnr
6
83
5.799805
65
20
36.5
204.75
null
1.299805
0.899902
143
7.299805
197
18
null
null
null
<2 mo. follow-up
2.157715
36
1
62.146
male
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
9
216,076
122,452.875
101,511
49.25
white
33.195313
59
0.518921
0.401978
12
1
0
no
null
null
no dnr
27
80
7.199219
65
14
35.29688
null
null
0.899902
0.899902
139
null
93
19
null
null
5
<2 mo. follow-up
5
27
1
30.672
female
1
4
MOSF w/Malig
ARF/MOSF
3
10
null
9
35,140
20,746.8125
20,754
35
black
39.59375
51
0.220978
0.122986
6
0
0
yes
0.2
0.1
dnr after sadm
4
77
21.597656
70
20
38.09375
null
null
0.399963
0.799927
139
null
173
9
2,625
null
0
<2 mo. follow-up
0
4
1
52.59998
male
0
7
CHF
COPD/CHF/Cirrhosis
2
15
$25-$50k
0
8,361
5,628.3125
5,935
7.5
white
22.5
41
0.870972
0.785889
1
0
0
no
null
null
no dnr
7
52
10.599609
125
26
39.19531
191.40625
null
6
5.5
145
7.399414
111
56
1,755
0
0
SIP>=30
0
875
0
67.685
female
0
39
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
55
null
41,386.75
42,966
21
black
23.296875
49
0.572998
0.461975
4
0
0
no
0.6
0.5
dnr after sadm
9
0
24.199219
0
0
36.5
413.3125
null
null
2.099609
143
7.40918
167
46
1,180
null
0
<2 mo. follow-up
0
49
1
75.85797
female
1
19
MOSF w/Malig
ARF/MOSF
1
13
$25-$50k
41
128,017
71,371.9375
68,692
52
white
31.398438
61
0.207977
0.112991
6
0
0
yes
0.1
0.05
dnr after sadm
3
69
null
68
12
36.19531
null
null
null
null
140
null
null
null
null
null
0
<2 mo. follow-up
0
19
1
68.40796
female
0
102
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
null
206,201.625
221,725
45.75
white
25
45
0.753906
0.675903
3
1
0
no
0.2
0.15
no dnr
102
0
18.699219
0
32
38.59375
69
1.199951
null
6.399414
141
7.289062
154
82
1,560
null
0
adl>=4 (>=5 if sur)
0
465
1
51.23297
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
61
18,435
11,561.6641
10,092
24.5
black
24.597656
41
0.661987
0.563965
1
0
0
no
0.6
0.55
dnr after sadm
3
78
5.699219
50
24
36.69531
null
null
0.599976
0.799927
139
null
93
8
null
null
7
<2 mo. follow-up
7
8
1
63.655
male
0
5
CHF
COPD/CHF/Cirrhosis
2
14
null
0
3,472
2,695.6484
2,398
6
black
23.597656
20
0.824951
0.713989
1
1
0
no
0.8
0.5
no dnr
5
78
6.199219
65
20
37.29688
null
null
25.5
1
136
null
115
8
1,500
0
null
no(M2 and SIP pres)
0.494751
271
1